398 related articles for article (PubMed ID: 2549203)
1. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
Rosen PP; Groshen S; Saigo PE; Kinne DW; Hellman S
J Clin Oncol; 1989 Sep; 7(9):1239-51. PubMed ID: 2549203
[TBL] [Abstract][Full Text] [Related]
2. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
Rosen PR; Groshen S; Saigo PE; Kinne DW; Hellman S
J Clin Oncol; 1989 Mar; 7(3):355-66. PubMed ID: 2918331
[TBL] [Abstract][Full Text] [Related]
3. Prognosis in stage II (T1N1M0) breast cancer.
Rosen PP; Saigo PE; Braun DW; Weathers E; Kinne DW
Ann Surg; 1981 Nov; 194(5):576-84. PubMed ID: 6271083
[TBL] [Abstract][Full Text] [Related]
4. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
5. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
Willner J; Kiricuta IC; Kölbl O
Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years.
Rosen PP; Groshen S
Surg Clin North Am; 1990 Aug; 70(4):937-62. PubMed ID: 2371651
[TBL] [Abstract][Full Text] [Related]
7. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.
Dawson PJ; Ferguson DJ; Karrison T
Cancer; 1982 Nov; 50(10):2131-8. PubMed ID: 6290024
[TBL] [Abstract][Full Text] [Related]
8. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up.
Rosen PP; Groshen S; Kinne DW; Hellman S
Surgery; 1989 Nov; 106(5):904-10. PubMed ID: 2814824
[TBL] [Abstract][Full Text] [Related]
9. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
[TBL] [Abstract][Full Text] [Related]
13. Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy?
Rosen PP; Kinne DW; Lesser M; Hellman S
Cancer; 1986 Apr; 57(7):1415-20. PubMed ID: 3004690
[TBL] [Abstract][Full Text] [Related]
14. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
15. Nonmammary malignant neoplasms in patients with stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. A long-term follow-up study.
Rosen PP; Groshen S; Kinne DW; Hellman S
Am J Clin Oncol; 1989 Oct; 12(5):369-74. PubMed ID: 2801596
[TBL] [Abstract][Full Text] [Related]
16. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
17. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
18. Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction.
Patterson SG; Teller P; Iyengar R; Carlson GW; Gabram-Mendola SG; Losken A; Styblo T; Torres M; Wood WC; Perez SD; Mosunjac M; Rizzo M
Ann Surg Oncol; 2012 Aug; 19(8):2679-84. PubMed ID: 22476750
[TBL] [Abstract][Full Text] [Related]
19. DCIS treated with excision alone using the National Comprehensive Cancer Network (NCCN) guidelines.
Wehner P; Lagios MD; Silverstein MJ
Ann Surg Oncol; 2013 Oct; 20(10):3175-9. PubMed ID: 23975306
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
